Search research articles
Contact Us
Filters
Showing results (141-150 of 274) with videos related to
Page
of 28
Sort By:
Scientific Reports
|
March 19, 2021
Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer
Mamta Parikh, Chengfei Liu, Chun-Yi Wu, et al.
Cancers
|
December 11, 2022
The Impact of Facility Surgical Caseload Volumes on Survival Outcomes in Patients Undergoing Radical Cystectomy
Giovanni E Cacciamani, Afsaneh Barzi, Michael B Eppler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 10, 2014
Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials
Primo N Lara, James Moon, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 4, 2016
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay
Primo N Lara, James Moon, Paul J Hesketh, et al.
American Journal of Hematology
|
July 12, 2002
Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial
Stephen E Wang, Primo N Lara, Angie Lee-Ow, et al.
Cancer
|
November 17, 2007
Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign
Ari Umutyan, Christine Chiechi, Laurel A Beckett, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 6, 2011
Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial
Randeep Sangha, Angela M Davies, Primo N Lara, et al.
Cancer Chemotherapy and Pharmacology
|
March 30, 2017
A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer
Heather A Wakelee, Scott Gettinger, Jeffrey Engelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 2, 2008
The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study
Angela M Davies, Christopher Ruel, Primo N Lara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2015
Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib
Primo N Lara, Jeff Longmate, Philip C Mack, et al.
Page
of 28
Search research articles
Search
Showing results (141-150 of 274) with videos related to
Sort By:
Page
of 28
Scientific Reports
|
March 19, 2021
Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer
Mamta Parikh, Chengfei Liu, Chun-Yi Wu, et al.
Cancers
|
December 11, 2022
The Impact of Facility Surgical Caseload Volumes on Survival Outcomes in Patients Undergoing Radical Cystectomy
Giovanni E Cacciamani, Afsaneh Barzi, Michael B Eppler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 10, 2014
Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials
Primo N Lara, James Moon, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 4, 2016
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay
Primo N Lara, James Moon, Paul J Hesketh, et al.
American Journal of Hematology
|
July 12, 2002
Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial
Stephen E Wang, Primo N Lara, Angie Lee-Ow, et al.
Cancer
|
November 17, 2007
Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign
Ari Umutyan, Christine Chiechi, Laurel A Beckett, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 6, 2011
Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial
Randeep Sangha, Angela M Davies, Primo N Lara, et al.
Cancer Chemotherapy and Pharmacology
|
March 30, 2017
A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer
Heather A Wakelee, Scott Gettinger, Jeffrey Engelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 2, 2008
The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study
Angela M Davies, Christopher Ruel, Primo N Lara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2015
Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib
Primo N Lara, Jeff Longmate, Philip C Mack, et al.
Page
of 28